The Impact of Linoleic Acid on Infant Health in the Absence or Presence of DHA in Infant Formulas
Open Access
Abstract
Both linoleic acid (LA) and α-linolenic acid (ALA) are essential dietary fatty acids, and a balanced dietary supply of these is of the utmost importance for health. In many countries across the globe, the LA level and LA/ALA ratio in breast milk (BM) are high. For infant formula (IF), the maximum LA level set by authorities (e.g., Codex or China) is 1400 mg LA/100 kcal ≈ 28% of total fatty acid (FA) ≈ 12.6% of energy. The aims of this study are: (1) to provide an overview of polyunsaturated fatty acid (PUFA) levels in BM across the world, and (2) to determine the health impact of different LA levels and LA/ALA ratios in IF by reviewing the published literature in the context of the current regulatory framework. The lipid composition of BM from mothers living in 31 different countries was determined based on a literature review. This review also includes data from infant studies (intervention/cohort) on nutritional needs regarding LA and ALA, safety, and biological effects. The impact of various LA/ALA ratios in IF on DHA status was assessed within the context of the current worldwide regulatory framework including China and the EU. Country averages of LA and ALA in BM range from 8.5–26.9% FA and 0.3–2.65% FA, respectively. The average BM LA level across the world, including mainland China, is below the maximum 28% FA, and no toxicological or long-term safety data are available on LA levels > 28% FA. Although recommended IF LA/ALA ratios range from 5:1 to 15:1, ratios closer to 5:1 seem to promote a higher endogenous synthesis of DHA. However, even those infants fed IF with more optimal LA/ALA ratios do not reach the DHA levels observed in breastfed infants, and the levels of DHA present are not sufficient to have positive effects on vision. Current evidence suggests that there is no benefit to going beyond the maximum LA level of 28% FA in IF. To achieve the DHA levels found in BM, the addition of DHA to IF is necessary, which is in line with regulations in China and the EU. Virtually all intervention studies investigating LA levels and safety were conducted in Western countries in the absence of added DHA. Therefore, well-designed intervention trials in infants across the globe are required to obtain clarity about optimal and safe levels of LA and LA/ALA ratios in IF.Keywords
Funding Information
- Bunge Loders Croklaan Nutrition
This publication has 126 references indexed in Scilit:
- Comparison of the fatty acid composition of transitional and mature milk of mothers who delivered healthy full-term babies, preterm babies and full-term small for gestational age infantsEuropean Journal of Clinical Nutrition, 2013
- Docosahexaenoic acid in maternal and neonatal plasma phospholipids and milk lipids of Taiwanese women in Kinmen: fatty acid composition of maternal blood, neonatal blood and breast milkLipids in Health and Disease, 2013
- Fatty acid compositions of preterm and term colostrum, transitional and mature milks in a sub-Saharan population with high fish intakesProstaglandins, Leukotrienes and Essential Fatty Acids, 2012
- Antioxidant capacity of human milk and its association with vitamins A and E and fatty acid compositionActa Paediatrica, 2009
- Women’s Dietary Patterns Change Little from Before to During Pregnancy , ,The Journal of Nutrition, 2009
- Update on alpha-linolenic acidNutrition Reviews, 2008
- Urban Demand for Edible Oils and Fats in China: Evidence from Household Survey DataJournal of Comparative Economics, 2002
- Fatty acid composition of human milk during the 1st month after term and preterm deliveryEuropean Journal of Pediatrics, 1997
- Determination of the optimal ratio of linoleic acid to α-linolenic acid in infant formulasThe Journal of Pediatrics, 1992
- The influence of a vegetarian diet on the fatty acid composition of human milk and the essential fatty acid status of the infantThe Journal of Pediatrics, 1992